Aylin ÖZGEN, Şakar Ayşin COŞKUN, Nesrin YAMAN, Ece KAYA, Pınar ÇELİK, Arzu YORGANCIOĞLU, Ömer AYDEMİR

Akciğer kanserli hastaların hastalıkları ile ilgili tutumları

Akciğer kanserli hastalarda hastalıkla ilgili tutumları değerlendirmek, hastalığın tanısının anlatılması ve tedavi seçenekleri konusundaki yaklaşımımızı yönlendirebilir. Çalışmamızda akciğer kanserli hastaların tanılarını bilme, hastalığın etiyolojisi, tedavi yöntemleri ve alternatif tedaviler ile ilgili tutumları araştırıldı.Kliniğimizde akciğer kanseri tanısı alan 55 hastaya, tutumlarını ölçmeye yönelik bir anket yüz yüze görüşmeyle uygulandı. Tutumların güç derecesi 1 ile 4 arasında bir skalada sayısal olarak belirlendi ve en olumlu tutum 4, en olumsuz tutum ise 1 olarak kabul edildi. Her soru için tutumların güç derecesi hesaplandı.53 erkek, 2 kadın, evre 3B ve evre 4 akciğer kanserli 55 olgunun yaş ortalaması 62 ± 10 idi. %62 hasta hastalıklarının adını bildiğini ifade etti. Hastaların %33'ü hastalığının adını tümör, %16'sı kitle, %7'si yara, %6'sı zatürre olarak tanımlıyordu. Bu bilgileri, hastaların %93'ü doktorundan aldığını ifade etti. Hastaların %71'i, hastalıklarının seyrinin iyi olmadığını bilse bile, bunun söylenmesini istemişti. Tedavi seçimini tümüyle doktoruna bırakan hasta sayısı %79 idi. Hastalığın etiyolojisi ve hastalık hakkında bilgilendirilme ile ilişkili tutumları olumluydu. Tedavi ile ilgili tutumlardan kemoterapi için kısmen olumlu, cerrahi tedavi için olumsuz, radyoterapi için kısmen olumsuz tutum saptandı. Alternatif tedavilerden şifalı otların etkisi ile ilgili tutumları olumsuza yakındı.Akciğer kanserli hastalarda tanı ve tedavi hakkında bilgilendirilme genellikle yetersizdir. Sonuçlarımız akciğer kanserli hastaların hastalıklarının nedeni ve tedavisi hakkında bilgilendirilmeye olumlu tutum sergilediklerini ortaya koymaktadır.

Attitudes of lung cancer patients to their disease

Evaluating the attitudes of lung cancer patients may direct our approaches of describing the diagnosis and treatment options. In our study, we researched the information of lung cancer patients about the diagnosis and their attitudes towards the etiology, treatment options and alternative therapies.A questionnaire measuring the attitudes was performed to 55 lung cancer patients by face-toface interview.Attitude power levels were determined in a scale ranging from 1 to 4 and the most positive attitude was regarded as 4, while the most negative was 1. Attitude power levels were measured for each question.Mean age of 55 patients (53 male, 2 female) with stage 3B and stage 4 lung cancer was 62±10.62% of patients mentioned that they knew their diagnosis. 33% of the patients described their disease as tumour, 16% as mass, 7% as wound, 6% as pneumonia. 93% of patients told that they were informed by their doctor.71% of the patients wanted to be told about the prognosis of their disease even though it was poor. 79% completely left their treatment decision to their doctor. Attitudes of the patients about the etiology and being informed about their disease were positive. Within the attitudes about the treatment options, the attitudes about chemotherapy were nearly positive, surgery were negative and nearly negative about radiotherapy. Within alternative methods the attitudes towards herbal therapy were also nearly negative.Generally, the patients with lung cancer aren't being informed enough about the diagnosis and treatment of their disease. Our results suggest that lung cancer patients have a positive attitude towards being informed about the diagnosis and treatment of their disease.

PDF

___

1. Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 2004; 22: 1721-30.
2. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York: Oxford University Pres, 1986.
3. Veatch RM. A T heory of Medical Ethics. New York: Basic Books, 1981.
4. Appelbaum PS, Lidz CW, Meisel A. Informed Consent: Legal Theory and Clinical Practice. New York: Oxford University Press, 1987.
5. Costain Schou K, Hewison J. Experiencing cancer: Bucki ngham: Open University Pres, 1999.
1. Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 2004; 22: 1721-30.
2. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York: Oxford University Pres, 1986.
15. Cho DY. Attitudes of Korean physicians toward telling-truth to the dying patient. J Korean Neuropsychiar Assoc 1981; 20: 1-16.
16. Han SW, Chung HY, Han SH. A study on the attitudes toward dying patients. J Korean Neuropsychiar Assoc 1990; 29: 1408-25.
17. Quirt CF, Mackillop WJ, Ginsburg AD, Sheldon L, Brundage M, Dixon P, Ginsburg L. Do doctors know when their patients donÕt? A survey of doctor Ðpatient communication in lung cancer. Lung Cancer 1997; 18:1-20.
18. Chu DT, Kim SW, Kuo HP, Ozacar R, Salajka F, Krishnamurthy S, Damyanov D, Altug S, Reece WH, Wang L. Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer. Lung Cancer 2007; 56: 433-43. Epub 2007 Mar 7.
19. Freedman B. Offering truth: One ethical approach to the uninformed cancer patient. Arch Intern Med 1993; 153: 572-6.
20. Gattellari M, Voigt KJ, Butow PN, Tattersall MH. When the treatment goal is not cure: Are cancer patients equipped to make informed decisions? J Clin Oncol 2002; 20: 503-13.
6. Leydon G, Boulton B, Moynihan C, Jones A, Mossman J, Boudioni M, McPherson K. Cancer patientsÕ information needs and information seeking behavior: in depth interview study. BMJ 2000; 320: 909-13.
7. Weeks JC, Cook EF, OÕDay SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF Jr, Lynn J, Phillips RS. Relationship between patientsÕ predictors of prognosis and their treatment preferences. JAMA 1998; 279: 1709-14.
8. The AM, Hak T, Koeter G, van der Wal Gerrit. Collusion in doctor-patient communication about imminent death: an ethnographic study. BMJ 2002; 321: 1376-81.
9. Yun YH, Lee CG, Kim S, Lee S, Heo DS, Kim JS, Lee KS, Hong YS, Lee JS, You CH. The attitudes of cancer patients and their families towards the disclosure of terminal illness. J Clin Oncol 2004; 22: 307-14.
10. Eidinger RN, Schapira DV. Cancer patientsÕ insight into their treatment, prognosis and unconventional therapies. Cancer 1984; 43: 2736-40.
11. Gattellari M, Butow PN, Tattersail MH, Dunn SM, MacLeod CA. Misunderstanding in cancer patients: Why shoot the messenger? Ann Oncol 1999; 10: 39-46.
12. Mackillop WJ, Stewart WE, Ginsburg AD, Stewart SS. Cancer patientsÕ perceptions of their disease and its treatment. Br J Cancer 1988; 58: 355-9.
13. Chariton RC. Breaking bad news. Med J Aust 1992; 157: 615-21.
14. Butow PN, Kazemi J, Beeney LJ, Griffin AM, Dunn SM, Tattersall MH. When the diagnosis is cancer: Patient communication experiences and preferences. Cancer 1996; 77: 2630-7.